PRKAA2 and hepatocellular carcinoma: Previous studies have documented that treatment of hepatocellular carcinoma cells with the AMPK activators, AICAR and metformin, significantly inhibited their proliferation, and induced cell cycle arrest at the G1-S phase (52).